Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_assertion type Assertion NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_head.
- NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_assertion description "[We speculate that engineering GLP-1-Gly8 secretion by beta-cells is a potential gene therapeutic strategy to treat diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_provenance.
- NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_assertion evidence source_evidence_literature NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_provenance.
- NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_assertion SIO_000772 15642594 NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_provenance.
- NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_assertion wasDerivedFrom befree-2016 NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_provenance.
- NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_assertion wasGeneratedBy ECO_0000203 NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_provenance.